Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CANDITRAL CAPSULE 100 MG - HSA Drug Approval Details

Approvals/HSA/CANDITRAL CAPSULE 100 MG

Approved

THERAPEUTIC

CANDITRAL CAPSULE 100 MG

GLENMARK PHARMACEUTICALS LTD (INDIA)🇸🇬 Health Sciences Authority

Approval Date: Jul 27, 2000
Approval ID: ade33f9be9c08e17
Company: GLENMARK PHARMACEUTICALS LTD (INDIA)
Type: Therapeutic

Approval Details

Approval Id: ade33f9be9c08e17
Drug Name: CANDITRAL CAPSULE 100 MG
Product Name: CANDITRAL CAPSULE 100 MG
Approval Number: SIN11355P
Approval Date: 2000-07-27
Registrant: UNI DRUG HOUSE
Licence Holder: UNI DRUG HOUSE
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: CAPSULE
Route Of Administration: ORAL
Atc Code: J02AC02
Atc Item Name: itraconazole
Pharma Manufacturer Name: UNI DRUG HOUSE SDN. BHD.
Company Detail Path: /organization/uni-drug-house-sdn-bhd

Active Ingredients

ITRACONAZOLE

100 mg

ITRACONAZOLE

100 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jul 27, 2000

Approval ID

ade33f9be9c08e17

Type

Therapeutic

Back to HSA Approvals